Tech Company Financing Transactions
Front Range Biosciences Funding Round
Front Range Biosciences closed a $10 million Series A funding round on 10/5/2018. Investors included Altitude Capital Partners, Cornerstone Opportunity Partners and Harvard Business School Angels of Chicago.
Transaction Overview
Cornerstone Opportunity Partners
Harvard Business School Angels of Chicago
Phyto Partners (Larry Schnurmacher)
Salveo Capital (Michael Gruber)
Welcan Capital (Vikas Desai)
Company Information
Boulder, CO 80304
USA
Management Team
Browse more venture capital transactions:
Prev: 10/4/2018: Braze venture capital transaction
Next: 10/5/2018: Basis venture capital transaction
Share this article
News on VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs